CYDY Mention - Look at this - people know about CYDY. One monetization catalyst like a BTD or a Philippines order or agressive dose escalation or the complete enrollment of the long hauler trial are all milestones between now and the end of the year that propell the stock. Unbelievable this is so low down here.

I love seeing articles like this - CYDY is relevant
https://www.benzinga.com/general/biotech/21/1...-antiviral